Neuronetics Inc (STIM)

$2.46 +0.18 (7.89%)
Market Cap 69.19M
Revenue (ttm) 71.35M
Net Income (ttm) -30.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -42.31%
Debt to Equity Ratio 4.90
Volume 650,100
Avg Vol 738,674
Day's Range N/A - N/A
Shares Out 30.35M
Stochastic %K 63%
Beta 2.11
Analysts Strong Sell
Price Target $2.67

Latest News on STIM

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dec 18, 2024, 4:30 PM EST - 4 weeks ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Dec 10, 2024, 10:00 AM EST - 5 weeks ago

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 8:30 AM EST - 2 months ago

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:41 PM EST - 2 months ago

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 6:45 PM EST - 2 months ago

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:10 AM EST - 2 months ago

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

Oct 29, 2024, 4:30 PM EDT - 2 months ago

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Oct 14, 2024, 8:31 AM EDT - 3 months ago

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Oct 4, 2024, 8:33 AM EDT - 3 months ago

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Sep 25, 2024, 8:31 AM EDT - 4 months ago

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

Sep 19, 2024, 8:31 AM EDT - 4 months ago

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

NeuroStar® Releases Software Upgrades to Elevate Patient Care

Sep 16, 2024, 8:32 AM EDT - 4 months ago

NeuroStar® Releases Software Upgrades to Elevate Patient Care

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Sep 3, 2024, 8:29 AM EDT - 4 months ago

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 1:59 PM EDT - 5 months ago

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Aug 12, 2024, 1:12 PM EDT - 5 months ago

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Aug 12, 2024, 7:15 AM EDT - 5 months ago

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 7:10 AM EDT - 5 months ago

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Aug 1, 2024, 8:29 AM EDT - 6 months ago

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Jul 30, 2024, 8:30 AM EDT - 6 months ago

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Jul 29, 2024, 8:30 AM EDT - 6 months ago

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

Jul 22, 2024, 8:31 AM EDT - 6 months ago

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

Jul 11, 2024, 8:36 AM EDT - 6 months ago

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents

Jul 10, 2024, 8:32 AM EDT - 6 months ago

BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents

NeuroStar® Launches Better Me Provider Program Nationwide

Jul 1, 2024, 8:02 AM EDT - 7 months ago

NeuroStar® Launches Better Me Provider Program Nationwide

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

Jun 13, 2024, 8:31 AM EDT - 7 months ago

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

May 23, 2024, 8:30 AM EDT - 8 months ago

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents

May 15, 2024, 7:32 AM EDT - 8 months ago

Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents

Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript

May 7, 2024, 5:16 PM EDT - 9 months ago

Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript

Neuronetics Reports Record First Quarter 2024 Financial and Operating Results

May 7, 2024, 7:30 AM EDT - 9 months ago

Neuronetics Reports Record First Quarter 2024 Financial and Operating Results

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

May 1, 2024, 8:31 AM EDT - 9 months ago

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

Apr 23, 2024, 4:30 PM EDT - 9 months ago

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

Apr 10, 2024, 8:31 AM EDT - 10 months ago

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

Mar 25, 2024, 8:30 AM EDT - 10 months ago

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

Mar 7, 2024, 8:22 AM EST - 11 months ago

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 12:19 PM EST - 11 months ago

Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript

Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results

Mar 5, 2024, 7:30 AM EST - 11 months ago

Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results

Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

Feb 20, 2024, 8:30 AM EST - 11 months ago

Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System

Feb 12, 2024, 8:32 AM EST - 1 year ago

Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System

NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update

Feb 6, 2024, 8:28 AM EST - 1 year ago

NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results

Jan 8, 2024, 8:30 AM EST - 1 year ago

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results

Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory

Dec 18, 2023, 8:49 AM EST - 1 year ago

Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory

NeuroStar TMS Receives Expanded Regulatory Approval in Japan

Dec 4, 2023, 8:56 AM EST - 1 year ago

NeuroStar TMS Receives Expanded Regulatory Approval in Japan

Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference

Nov 15, 2023, 4:15 PM EST - 1 year ago

Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

Nov 13, 2023, 8:57 AM EST - 1 year ago

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage

Nov 9, 2023, 8:32 AM EST - 1 year ago

Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage

Neuronetics, Inc. (STIM) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:00 PM EST - 1 year ago

Neuronetics, Inc. (STIM) Q3 2023 Earnings Call Transcript

Neuronetics Reports Third Quarter 2023 Financial and Operating Results

Nov 7, 2023, 7:30 AM EST - 1 year ago

Neuronetics Reports Third Quarter 2023 Financial and Operating Results

Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call

Oct 24, 2023, 8:30 AM EDT - 1 year ago

Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call

Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes

Oct 16, 2023, 8:56 AM EDT - 1 year ago

Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes

Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility

Oct 3, 2023, 9:21 AM EDT - 1 year ago

Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility